In vitro activity of lomefloxacin (SC 47111 or NY-198), a new quinolone antimicrobial, against clinical isolates of common pathogens
- 30 June 1989
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (3) , 21-28
- https://doi.org/10.1016/0732-8893(89)90061-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969)Antimicrobial Agents and Chemotherapy, 1988
- In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolonesAntimicrobial Agents and Chemotherapy, 1988
- In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agentsAntimicrobial Agents and Chemotherapy, 1988
- Specific Toxicologic Aspects of the QuinolonesClinical Infectious Diseases, 1988
- In vitro and in vivo activity of NY-198, a new difluorinated quinoloneAntimicrobial Agents and Chemotherapy, 1987
- The influence of quinolone derivatives on theophylline clearance.British Journal of Clinical Pharmacology, 1986
- In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1986
- In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivativeAntimicrobial Agents and Chemotherapy, 1986
- New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assayJournal of Medicinal Chemistry, 1986
- The fluoroquinolones: pharmacology, clinical uses, and toxicities in humansAntimicrobial Agents and Chemotherapy, 1985